Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc

Bullboard Posts

Comment by vikingguyon Jul 16, 2020 2:49pm

104 Views

Post# 31277409

RE:Covid-19 traction coming

I think you are correct NewFan, some news regarding our patent application for applying CBD to Covid patients will bring much needed attention to this story. That coupled with our product being available on Shoppers website (anyday now) will turn this around. Any other nice surprises along the way and look out. Cheers

Bullboard Posts

Canadian artificial intelligence ETFs